GEMCITABINE ACTAVIS 200 MG/VIAL

国: イスラエル

言語: 英語

ソース: Ministry of Health

有効成分:

GEMCITABINE 200 MG/VIAL

から入手可能:

DEVRIES & CO. LTD

ATCコード:

L01BC05

医薬品形態:

POWDER FOR SOLUTION FOR INFUSION

投与経路:

I.V

製:

ACTAVIS GROUP PTC ehf, ICELAND

治療群:

GEMCITABINE

適応症:

Gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer in combination with cisplatin. Gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas.Gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC). Gemcitabine monotherapy can be considered in elderly patients or those with performance status 2. Gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum-based, first-line therapy. Gemcitabine, in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. Prior chemotherap

承認日:

2013-06-01